Workflow
中基健康:困境中坚守主业,“化工+食品加工”双轮驱动突围

Core Viewpoint - The company, Zhongji Health, reported significant financial losses in 2024 due to a challenging market environment, while also exploring strategic transformations to mitigate risks associated with its primary tomato processing business [1][3]. Group 1: Financial Performance - In 2024, Zhongji Health achieved total revenue of 308 million yuan but incurred a net loss of 231 million yuan attributable to the parent company [1]. - The company's gross profit margin for domestic operations was 24.76%, reflecting a year-on-year increase of 0.83% [3]. - Despite a 49.78% increase in the production of bulk tomato sauce to 173,600 tons, the overall performance remained in the red [3]. Group 2: Industry Challenges - The tomato processing industry is experiencing oversupply, leading to intensified competition and increased difficulty in sales [2]. - In 2024, China's tomato sauce export volume decreased by approximately 40%, with export prices dropping from around 1,200 USD/ton to about 700 USD/ton, marking a decline of over 40% [2]. Group 3: Strategic Initiatives - Zhongji Health is initiating a transformation by acquiring a majority stake in Xinjiang Xinye Energy Chemical Co., aiming to diversify its business and reduce reliance on the tomato processing sector [4][5]. - The acquisition is expected to enhance the company's production efficiency and resource utilization, establishing a dual business model of food processing and chemical production [6]. - The company plans to fully advance its strategic restructuring and aims to integrate into the regional economic development initiatives in Xinjiang [7].